生物活性 | |||
---|---|---|---|
描述 | Isofangchinoline (Fangchinoline) is a bisbenzyltetrahydroisoquinoline alkaloid isolated from Stephania tetrandra, which may be an inactivator of nuclear NR4A1, as well as inhibited cell proliferation and induced apoptosis in human pancreatic cancer cells[2]. Fangchinoline inhibited osteoclastogenesis at doses of 0.5 and 1 µM. And fangchinoline down regulated NFATc1 activity and expression. However, fangchinoline did not affect IκBα degradation and MAPK pathways. Fangchinoline could protect against bone loss in OVX mice[3]. Moreover, fangchinoline attenuated the biochemical marker changes induced by DN (diabetic nephropathy) in blood and urine. The expression of p38 MAPK, TNF-α, COX-2, and MMP-9 was also attenuated by fangchinoline treatment in the kidney tissues of DN rats[4]. FAN (Fangchinoline) decreased the production of inflammatory cytokines and ROS in human FLS cells as well as the phosphorylation of the MAPK pathway and NF-κB pathway in human FLS (fibroblast-like synovial cells) cells. The behavioral parameters in the C/K rat model and CIA (collagen-induced arthritis) mouse model and inflammatory signs in the histological analysis were found to be ameliorated in FAN-treated groups. Cartilage degradation in CIA mice knee joints were shown to have been suppressed by FAN[5]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.64mL 0.33mL 0.16mL |
8.21mL 1.64mL 0.82mL |
16.43mL 3.29mL 1.64mL |
参考文献 |
---|